Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(33%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
4
67%
Ph phase_1
2
33%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(2)
Other(1)

Detailed Status

Recruiting2
Completed2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (33.3%)
N/A4 (66.7%)

Trials by Status

recruiting233%
unknown117%
completed233%
not_yet_recruiting117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
PROCEDURE
Total Trials
6